HVEM, the ligand of BTLA, was expressed at high levels on immune cells in PyMT-tumors and at lower variegated levels on tumor epithelial cells (Figure 1I), allowing the engagement of BTLA by several cells in the microenvironment of PyMT tumors. The gene discussed is TNFRSF14; the disease is neoplasm.